Journal profile · Physiology
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
ISSN 0305-1870 · eISSN 1440-1681 · Wiley-Blackwell Publishing Ltd · AUSTRALIA · Monthly · Founded 1974
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.43; hybrid open access; APC about USD 4,150; median 123 days to acceptance (80 articles, last 24 months); community-reported acceptance: about 20%; 103 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY is published by Wiley-Blackwell Publishing Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Nitric Oxide and Endothelin Effects, Receptor Mechanisms and Signaling and Renin-Angiotensin System Studies, together about 25% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Clinical and Experimental Pharmacology and Physiology is an international journal founded in 1974 by Mike Rand, Austin Doyle, John Coghlan and Paul Korner. Our focus is new frontiers in physiology and pharmacology, emphasizing the translation of basic research to clinical practice. We publish original articles, invited reviews and our exciting, cutting-edge Frontiers-in-Research series’.
Source: LetPub
Research area (LetPub): Physiology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Nitric Oxide and Endothelin EffectsMedicine10.1%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology8.1%
- Renin-Angiotensin System StudiesMedicine6.8%
- Heart Rate Variability and Autonomic ControlMedicine6.2%
- Hormonal Regulation and HypertensionMedicine6.2%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology5.8%
- Neuropeptides and Animal PhysiologyNeuroscience5.6%
- Cardiac electrophysiology and arrhythmiasMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Physiology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Physiology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Physiology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.43LetPub ·
- CiteScore 2026-06
- 5.6LetPub ·
- SJR 2026-06
- 0.63LetPub ·
- SNIP 2026-06
- 0.62LetPub ·
- h-index
- 95LetPub ·
- h-index
- 139OpenAlex ·
- i10-index
- 4,283OpenAlex ·
- 2-year mean citedness
- 2.03OpenAlex ·
- Self-citation rate
- 4%LetPub ·
- Share of gold OA articles
- 11.4%LetPub ·
Volume
- Articles per year
- 77LetPub ·
Articles by year OpenAlex count · 8,694 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 67 | 22 | 8 |
| 2025 | 103 | 44 | 195 |
| 2024 | 109 | 36 | 364 |
| 2023 | 100 | 41 | 522 |
| 2022 | 140 | 23 | 1,494 |
| 2021 | 173 | 30 | 1,959 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
123 daysMedian, submission to acceptance · P25–P75 96 days – 198 days
- Acceptance to online
- median 18 days (81 articles)
- Submission to online
- median 140 days
- Sample
- 80 articles with submission and acceptance dates (172 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 6 monthsLetPub ·
- Average acceptance (community reports)
- 20%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,150 / EUR 3,470 / GBP 2,780 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- AUSTRALIA
- Language
- English
- Frequency
- Monthly
- Founded
- 1974
- ISSN
- 0305-1870
- Electronic ISSN
- 1440-1681
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
What CAS zone is CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY in?
In the 2025 upgraded edition of the CAS Journal Ranking, CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy / Physiology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY?
The latest impact factor listed by LetPub is 2.43; CiteScore 5.6, h-index 139.
How long does peer review take at CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY?
Based on the dates recorded on 80 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 123 days (interquartile range 96–198 days); authors report an average review time of about 6 months; the community-reported acceptance is “about 20%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY?
According to LetPub and DOAJ records, CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY is indexed in SCIE and Scopus.
Is CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY open access, and what is the APC?
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY is a hybrid journal. For open-access publication: APC about USD 4,150.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .